Surgical strategies for non-functioning pancreatic neuroendocrine tumours
Authors:
Open Access
- 1 October 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 99 (11) , 1562-1568
Abstract
Background: The purpose of this study was to identify management strategies for non-functioning pancreatic neuroendocrine tumours (NF-PNETs) by analysis of surgical outcomes at a single institution. Methods: Archived records of patients with NF-PNETs who underwent surgery between 1994 and 2010 were reviewed. Results: Among 125 patients, the median tumour size was 2·5 (range 0·15–20·5) cm. Of the 51 NF-PNETs with a diameter of no more than 2 cm, 12 (24 per cent) were diagnosed as carcinoma. Overall 20 patients (16·0 per cent) had metastases to the lymph nodes. The minimum size of the tumour with lymph node metastasis was 1·2 cm. Having a NF-PNET of 2 cm or larger significantly increased the probability of a poorly differentiated carcinoma (P = 0·006), and having a NF-PNET of at least 2·5 cm significantly increased the probability of lymph node metastasis (P = 0·048). The 5-year cumulative survival rate after curative resection was 89·7 per cent. During a median follow-up of 31·5 months, there were 27 recurrences (23·1 per cent) and 13 disease-specific deaths (11·1 per cent) among the 117 patients who had an R0 resection. All patients who underwent repeat operations were alive without additional recurrence after a mean(s.d.) follow-up of 27·1(18·0) months. Conclusion: Curative surgery should be performed for control of primary NF-PNETs. Lymph node dissection for NF-PNETs of 2·5 cm or larger and at least node sampling for tumours with a diameter of 1 cm or more are recommended. Debulking surgery should be considered for advanced tumours.Keywords
This publication has 21 references indexed in Scilit:
- Preoperative diagnosis of nonfunctioning pancreatic neuroendocrine tumorsMedical Oncology, 2010
- Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumoursAnnals of Oncology, 2008
- Prognostic Score Predicting Survival After Resection of Pancreatic Neuroendocrine TumorsAnnals of Surgery, 2008
- Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreasBritish Journal of Surgery, 2008
- Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)Surgery, 2007
- Functioning and nonfunctioning neuroendocrine tumors of the pancreasCurrent Opinion in Oncology, 2007
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemVirchows Archiv, 2006
- Is Surgery Beneficial for MEN1 Patients with Small (≤2 cm), Nonfunctioning Pancreaticoduodenal Endocrine Tumor? An Analysis of 65 Patients from the GTEWorld Journal of Surgery, 2006
- Well-Differentiated Pancreatic Nonfunctioning Tumors/CarcinomaNeuroendocrinology, 2006
- Postoperative pancreatic fistula: An international study group (ISGPF) definitionSurgery, 2005